New Delhi, June 2 -- Gavi, the Vaccine Alliance, on Monday announced that it will make up to $50 million available through its First Response Fund (FRF) to support the response to the ongoing Bundibugyo ebolavirus outbreak, with the bulk of the funding earmarked to accelerate access to vaccines against the current strain.

Of the total allocation, up to $40 million will be used to speed up vaccine development and access, while a further $10 million will support outbreak response efforts.

"While we are some way off having a safe and effective vaccine against Bundibugyo virus, we need to act now to ensure that, once one or more vaccine candidates are ready, manufacturers are in a position to start producing doses at scale," said Sania Nish...